Peter A. Lankau, Executive Chairman of the Board
Mr. Lankau is an experienced biopharmaceutical executive with nearly 30 years of general management expertise in developing and commercializing pharmaceutical products. As the former CEO of Logical Therapeutics, Inc., a development stage biopharmaceutical company, he led the company in its development of NSAIDs for the chronic treatment of inflammatory disease and now serves on their Board of Directors.
Prior to Logical, Mr. Lankau was the former President and Chief Executive Officer, and member of the Board of Directors, of Endo Pharmaceuticals Inc., a publicly traded specialty pharmaceutical company where he led the company in developing its pipeline in the pain management and supportive oncology therapeutic areas, including more than 12 product acquisitions/licenses. His previous position was VP Sales and Marketing at Alpharma and he began his pharmaceutical career with Rhone-Poulenc Rorer, Inc. (now Sanofi-Aventis, Inc.) in multiple commercial roles, and was most recently Vice President, Sales-US Pharmaceuticals.
William Maichle, Chief Executive Officer
William Maichle has more than 15 years of experience in drug development, mergers and acquisitions, licensing, sales and marketing, and pharmaceutical operations. His career includes senior management positions at PharmaNet, Otsuka, and Kowa Pharmaceuticals America (formerly ProEthic Pharmaceuticals).
Neil Milano, Chief Financial Officer
Neil Milano came to Nautilus from Tailwind Capital where he was an operating partner since 2004. He has more than 30 years of experience as a chief financial officer or controller in a number of organizations, including Johnson & Johnson and several start-up companies.